Glaxosmithkline | GSK - Modal Dan Cadangan





Modal Dan Cadangan Perubahan Tanggal
AbbVie USD -3.27B 628M 2025-12
Amgen USD 9.19B 532M 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
Aurora Cannabis CAD 536.36M 30.74M 2025-12
Bausch Health Companies USD -2.06B 1.5B 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Canopy Growth CAD 758.17M 22.16M 2025-12
Corcept Therapeutics USD 637.99M 9.82M 2026-03
Drreddys Laboratories INR 4.14B 107.72M 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Glaxosmithkline GBP 22.06B 360M 2025-12
J&J USD 81.19B 358M 2026-03
Merck USD 45.88B 6.73B 2026-03
Novartis USD 38.93B 7.2B 2026-03
Pacira USD 653.89M 39.22M 2026-03
Perrigo USD 2.94B 1.51B 2025-12
Pfizer USD 90.1B 3.63B 2026-03
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 1.83B 4.48M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
Supernus Pharmaceuticals USD 1.08B 15.09M 2026-03
Takeda JPY 7.64T 513.39B 2025-12
Teva Pharmaceutical Industries USD 8.23B 314M 2026-03
Zoetis USD 3.33B 2.07B 2025-12